Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD | 27.90M | $522.0M | 12.77% | -- | 2026-06-30 |
| FMR LLC | 20.11M | $376.0M | 9.20% | +16.41M | 2026-06-30 |
| Casdin Capital, LLC | 16.04M | $300.0M | 7.34% | +1.62M | 2026-06-30 |
| BlackRock, Inc. | 15.29M | $286.0M | 7.00% | +2.31M | 2026-06-30 |
| PERCEPTIVE ADVISORS LLC | 14.11M | $263.0M | 6.45% | +4.36M | 2026-06-30 |
| Commodore Capital LP | 12.00M | $224.0M | 5.49% | -5.00M | 2026-06-30 |
| STATE STREET CORP | 10.13M | $189.0M | 4.63% | +3.89M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 8.96M | $167.0M | 4.10% | +1.58M | 2026-06-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.71M | $144.0M | 3.53% | +5.78M | 2026-06-30 |
| Nextech Invest Ltd. | 6.78M | $126.0M | 3.10% | +1.25M | 2026-06-30 |
